Century Therapeutics Inc
NASDAQ:IPSC

Watchlist Manager
Century Therapeutics Inc Logo
Century Therapeutics Inc
NASDAQ:IPSC
Watchlist
Price: 1.165 USD 5.91%
Market Cap: 99.1m USD
Have any thoughts about
Century Therapeutics Inc?
Write Note

Intrinsic Value

IPSC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one IPSC stock under the Base Case scenario is 0.368 USD. Compared to the current market price of 1.165 USD, Century Therapeutics Inc is Overvalued by 68%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IPSC Intrinsic Value
0.368 USD
Overvaluation 68%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Century Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for IPSC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about IPSC?
Bearish
Neutral
Bullish

Fundamental Analysis

1.165 USD
+5.91%
+5.91%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Century Therapeutics Inc
US
Biotechnology
Market Cap
98.5m USD
IPO
Jun 17, 2021
Employees
170
United States of America
Market Cap
98.5m USD
Industry
Biotechnology
IPO
Jun 17, 2021
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Century Therapeutics Inc

Provide an overview of the primary business activities
of Century Therapeutics Inc.

What unique competitive advantages
does Century Therapeutics Inc hold over its rivals?

What risks and challenges
does Century Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Century Therapeutics Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Century Therapeutics Inc.

Provide P/S
for Century Therapeutics Inc.

Provide P/E
for Century Therapeutics Inc.

Provide P/OCF
for Century Therapeutics Inc.

Provide P/FCFE
for Century Therapeutics Inc.

Provide P/B
for Century Therapeutics Inc.

Provide EV/S
for Century Therapeutics Inc.

Provide EV/GP
for Century Therapeutics Inc.

Provide EV/EBITDA
for Century Therapeutics Inc.

Provide EV/EBIT
for Century Therapeutics Inc.

Provide EV/OCF
for Century Therapeutics Inc.

Provide EV/FCFF
for Century Therapeutics Inc.

Provide EV/IC
for Century Therapeutics Inc.

Show me price targets
for Century Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Century Therapeutics Inc?

How accurate were the past Revenue estimates
for Century Therapeutics Inc?

What are the Net Income projections
for Century Therapeutics Inc?

How accurate were the past Net Income estimates
for Century Therapeutics Inc?

What are the EPS projections
for Century Therapeutics Inc?

How accurate were the past EPS estimates
for Century Therapeutics Inc?

What are the EBIT projections
for Century Therapeutics Inc?

How accurate were the past EBIT estimates
for Century Therapeutics Inc?

Compare the revenue forecasts
for Century Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Century Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Century Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Century Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Century Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Century Therapeutics Inc with its peers.

Analyze the financial leverage
of Century Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Century Therapeutics Inc.

Provide ROE
for Century Therapeutics Inc.

Provide ROA
for Century Therapeutics Inc.

Provide ROIC
for Century Therapeutics Inc.

Provide ROCE
for Century Therapeutics Inc.

Provide Gross Margin
for Century Therapeutics Inc.

Provide Operating Margin
for Century Therapeutics Inc.

Provide Net Margin
for Century Therapeutics Inc.

Provide FCF Margin
for Century Therapeutics Inc.

Show all solvency ratios
for Century Therapeutics Inc.

Provide D/E Ratio
for Century Therapeutics Inc.

Provide D/A Ratio
for Century Therapeutics Inc.

Provide Interest Coverage Ratio
for Century Therapeutics Inc.

Provide Altman Z-Score Ratio
for Century Therapeutics Inc.

Provide Quick Ratio
for Century Therapeutics Inc.

Provide Current Ratio
for Century Therapeutics Inc.

Provide Cash Ratio
for Century Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Century Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Century Therapeutics Inc?

What is the current Free Cash Flow
of Century Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Century Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Century Therapeutics Inc

Current Assets 206m
Cash & Short-Term Investments 198.1m
Other Current Assets 7.9m
Non-Current Assets 182.6m
Long-Term Investments 46.6m
PP&E 94.1m
Intangibles 38.5m
Other Non-Current Assets 3.4m
Current Liabilities 19.8m
Accounts Payable 2.6m
Accrued Liabilities 13.4m
Other Current Liabilities 3.9m
Non-Current Liabilities 173.1m
Other Non-Current Liabilities 173.1m
Efficiency

Earnings Waterfall
Century Therapeutics Inc

Revenue
2.7m USD
Operating Expenses
-134.2m USD
Operating Income
-131.5m USD
Other Expenses
1.6m USD
Net Income
-129.9m USD

Free Cash Flow Analysis
Century Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

IPSC Profitability Score
Profitability Due Diligence

Century Therapeutics Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive 1-Year Revenue Growth
Declining ROIC
Declining ROE
18/100
Profitability
Score

Century Therapeutics Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

IPSC Solvency Score
Solvency Due Diligence

Century Therapeutics Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Low D/E
Long-Term Solvency
68/100
Solvency
Score

Century Therapeutics Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IPSC Price Targets Summary
Century Therapeutics Inc

Wall Street analysts forecast IPSC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPSC is 9.86 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Lowest
Price Target
5.05 USD
333% Upside
Average
Price Target
9.86 USD
746% Upside
Highest
Price Target
12.6 USD
982% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IPSC?

Click here to dive deeper.

Dividends

Century Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IPSC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IPSC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one IPSC stock?

The intrinsic value of one IPSC stock under the Base Case scenario is 0.368 USD.

Is IPSC stock undervalued or overvalued?

Compared to the current market price of 1.165 USD, Century Therapeutics Inc is Overvalued by 68%.

Back to Top